Skip to Navigation | Skip to Main Content | Skip to Site Map | Mobile Site

Senate Tracker: Sign Up | Login

The Florida Senate

HB 1183: Prescription Drug Price Transparency


Prescription Drug Price Transparency; Prohibits renewal of permits for prescription drug manufacturers & wholesale distributors unless specified requirements are met; provides reporting requirements for entities that engage in wholesale distributions of prescription drugs; provides requirements for notifications by manufacturers of prescription drug price increases; provides reporting requirements by manufacturers of drug prices; prohibits prescription drugs from being included in specified drug formularies; provides penalties & fines for violations; provides reporting requirements for registered pharmacy benefit managers; requires health insurers & HMOs to notify insureds & subscribers of drug formulary changes; requires pharmacy benefit managers to maintain a website for access to net prices of prescription drugs.

Effective Date: 7/1/2022
Last Action: 3/14/2022 House - Died in Finance & Facilities Subcommittee
Bill Text: PDF

Bill History

Date Chamber Action
1/5/2022 House • Filed
1/10/2022 House • Referred to Finance & Facilities Subcommittee
• Referred to Appropriations Committee
• Referred to Health & Human Services Committee
• Now in Finance & Facilities Subcommittee
1/11/2022 House • 1st Reading (Original Filed Version)
3/12/2022 House • Indefinitely postponed and withdrawn from consideration
3/14/2022 House • Died in Finance & Facilities Subcommittee